| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| amp-pnp | ephrin type-a receptor 2 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| amp-pnp | ephrin type-b receptor 2 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| amp-pnp | glycogen synthase kinase-3 beta | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| amp-pnp | insulin-like growth factor i receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| amp-pnp | lck tyrosine protein kinase | NA | Successful target | TTD | NA | NA | investigative | unknown |
| amp-pnp | stress-activated protein kinase jnk3 | NA | Patented-recorded target | TTD | NA | NA | investigative | unknown |
| amp-pnp | map kinase p38 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| amp-pnp | dna topoisomerase ii beta | NA | Successful target | TTD | NA | NA | investigative | unknown |
| amp-pnp | long transient receptor potential channel 4 | NA | Clinical trial target | TTD , DGIDB | NA | NA | investigative | inhibitor |
| click here to return to the previous page | ||||||||